EUVIMEDEUVIMED entdecken
Crossref

How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway

Gideon Ptasznik iD, Brian D Kelly, Declan Murphy iD, Nathan Lawrentschuk iD, Veeru Kasivisvanathan iD, Mark Page, Sean Ong iD, Daniel Moon iD

BJU International · 2024

DOI: 10.1111/bju.16175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Gideon Ptasznik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstateProstatic NeoplasmsMaleHumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyGallium RadioisotopesProstate-Specific Antigen

Substanzen

Gallium RadioisotopesProstate-Specific Antigen

Autor:innen und Institutionen

  • Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Young Urology Research Organisation, Melbourne, VIC, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Division of Surgery and Interventional Science, University College London, London, UK.
  • Division of Medical Imaging, St. Vincents Hospital (Melbourne Victoria), Melbourne, VIC, Australia.

ORCID-Profile: Gideon Ptasznik, Declan Murphy, Nathan Lawrentschuk, Veeru Kasivisvanathan, Sean Ong, Daniel Moon

Zitieren

APA

Ptasznik, G., Kelly, B. D., Murphy, D., Lawrentschuk, N., Kasivisvanathan, V., Page, M., Ong, S., & Moon, D. (2024). How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway. BJU International. https://doi.org/10.1111/bju.16175

Vancouver

Ptasznik G, Kelly BD, Murphy D, Lawrentschuk N, Kasivisvanathan V, Page M, et al. How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway. BJU International. 2024. doi:10.1111/bju.16175

BibTeX
@article{Ptasznik2024,
  author = {Ptasznik, Gideon and Kelly, Brian D and Murphy, Declan and Lawrentschuk, Nathan and Kasivisvanathan, Veeru and Page, Mark and Ong, Sean and Moon, Daniel},
  title = {How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16175}
}
Kostenlos starten →